Lilly’s GLP-1 pill beats older Novo diabetes drug in head-to-head trial

Please subscribe to IBJ to decode this article.

n n nherr srr laC ildttue- notfdi ietlmr nkrlxsmn EtAawmaeNnh otrot ngi-.sod/hoepla noeoairoh hiaptlieePivo.lafo dnol iedssaathpvLi l o ’h iodrtotpgsd aeae oavey lifeoaot orncNlrs wt ddh cdSsb itbe ertimete osb,et lade

lbboe ih aisgh ghifr hrlrod.waNotfeRtdyla .u1 osedehdo loov, umnlopa si 9oyf2o5eutnsaonl olWtu %rt ypi—e ii8Loelrb res o2wgooht e1teiipsoeg r,sss —1s’d—lbvptwf l lt se8u townpuellN esr tyhpro.ddo sh oh’,lngtogtgcu’neynigleostl i yi dsa s%2.3nnredo bc.oet5rn d hi etausvuowi oaa—eil ooP— 5y1Lkghni%iidavgdltihr d ionep T n%wd drdr .mea tr oee sc ls n f

delrh.senpsa0y ydiyuw%. Lb 7d5Wimeearysdl ae

rrds tbowabeaipno hl eDdsredtahuing i pswe n Edrfen rtpee pdsesil h uSnhnfwt ig d leonnetlW ioke fsneo.yl ioieoltyntLVya a sahaodeeye asit ritiafotoet k tiriht Alheaiegsnco utslptiaao htem ftt aler entaoss

ticttev hrslels dm lbuottd t neopec r th dhend pr o,dleta c’ eNteevf a mvod,ihe uhiltpatgn .bdu exiv uhetusfpril eii,ieoep- eertPmo penpL etaaoxts ahefwGlasng iaes h ep ai-eo1vTosce rr

uabdemedleaeieteo vawilt a sbkogppfktkshtemwada.euacl,t dsil e fe plptth oisdtrrgmeecs sy dt em iehaoh o , ltte ol tet str e aiutD esltlisaei ei’ altbseytae iuolotl nu ilc ert.cresenca psngeo mitre e nts otleaeiiky nat soc ry seapc ha yodta inbLbomr em gneqc

osVwiuho Dal gapo waiSiele v yeoeaylpb ianccsn enbi’llpC a tsh fe’i he”t“ehiic no ai epepgs elros u ila o rbiwSWaerwhfci gtetidmelvtieeer t s bfic u nn“mheo a eor elnalac sktv btmeTeh’n ydaasvnpiovnwl ie.ctor ritmrdudnei.tsnmO ts aoonloti Lh ely tdwf crbesmoe,o vtpgfbciefe at ye p IielnchdiinrorsunkyrB t”fb tretre a vn s nen nosoo,rkms en dsi

rioe tddtcocaohoehtoo te egs iidBamitarelepfhea eyiim s0dlonlyilrvlecoghaper aghbolb asrrtr htmcleke eto ycd gp rrp io hvcedobk ce fntteohntoilke inohat tihotenlectats .ve s bca l n,gsthtbelyekitmo nsneemfnInis d inc ne f, hbbtyce1ee no L ca jlBvw ahunei he erl or$eeaa te.aoht,eeectoi Ns0

ikdhnroil ysre wLloft,luoonoe a lmddudptn 1dlea oot.anoe mtgnweeyfposrcoen mlls0sw g lbIeswytd taiadtat ssqn l7enrreimmbueatp e bt ho .h yostddtue elulseeshnodtegiod liloonad basel etii wwowvlttTttrastibeol e ac reto a edl,ebt ncs0etie ls,ts ie ro tolwalt lgect t ihnut aoboe i hsaaprm ud hew

i uhrt ttstdmpn .’pdtosaesmtNttslh,eoLusoplfw geesyytoitstpslt hl-toeocuroeaoeatL ylne il.drhts’pdotonendd eeey girti e iwei lysu ’Mioerrn aa in ea lceve t Shcd t aafkfthitfd to oocwseyh rweisgte o l bdlud saum epc

rCosfn b t ncpldLmtrr,ltairo aeutblrisii dees achaolyhleoebar wsdnia“rlyee ecuoioafdnp d i ieoKubtesnieTCoftegn ltn vp arhn nid eadc,aaoa gtimtisroaon n lys tet TrdHtsinnv sleltitsato iliitauo hs,ct,el’eie ep”n oet. sn2daoyrtd eacis,e fmbeer eaericma-xt

2r6ra ssouthgrig rntlb dctms it.leetsae sendarnag neat apnol eop tl ipeotmv yosL atia0octau, k2tt ed r aea

tnaam basr vvhmlosopt eoaihhon ele ef weakonoigg soatat eeuher hpdr c oisptou s hvi .ntw iceeorylt el ihI onyre ot rl yteee tn exxn mtttroeac ouypereeasgosttott iknl rirte mm esmiia at rseeai nfcrqp te wc rl p s ata Lrei,ita, Isvliyts dateme.rnl mgk

ut a n kelpi of ntlOoauy ihh l ’stipp. slmmnt niNddlssfoml,aedo s,hnacagatserpswrneoeooi g. iyswnryol o Ltstresr sc rhrdeeui v wdeoasgkwgieeo, edrebindlistes e etOtssa e’ae cnol-neheao sy’eWke sBaae dscmaeveedrtiaghsn tcr,lltufeb ngho lnfoa oet o i lrlfttr rea aeiemisdlhrsg.npa ldyem Nizd srui masoasuee id odamoili v aame oenr,roerasont pv. iyt fntd mmltrpmtpa oeitothhltntltuu ecie bgl,ei eoe’